Process patent legislation
Executive Summary
Rep. Moorhead (R-Calif.) on Feb. 7 introduced a bill which makes it patent infringement to import, use, or sell in the U.S. products, including drugs, made by a patented process; exempts from damages infringers other than mfrs. who lack knowledge or notice of infringement; and places on alleged infringers the burden of proving products in question are not produced by the patented process. The bill applies to goods produced or imported after enactment. A similar bill introduced last year passed the Senate after pharmaceuticals were exempted. Congress adjourned before it was reconciled with a House-passed version